Introducing Seegene Mobile Station
High Multiplex RT-PCR Testing for COVID-19 and Other Pathogens
Blog
Catching Up With The COVID-19 Variants
According to the COVID tracking project, over 355 million tests have been performed in the United States as of March 2021. The tests have played
The Rapid Evolution of Seegene’s COVID-19 Solutions
It’s been one year since Seegene produced a complete respiratory diagnostic test that has taken the uncertainty out of differentiating COVID-19 infection from other respiratory
The Future of Diagnostics: Syndromic Assays
How High Multiplex assays that test for many common pathogens at once can accelerate diagnostics and facilitate a higher quality of care When a patient
Press Releases
Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants
Published on: PR Newswire SEEGENE LAUNCHES FIRST MULTIPLEX TEST TO IDENTIFY COVID-19 MUTANTS THE MANUFACTURER OF COVID-19 TESTS CONTINUOUSLY FOLLOWS THE SPREAD OF THE VARIANTS
Seegene introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with dual internal controls
SEOUL, South Korea, Sept. 8, 2020 /PRNewswire/ — Seegene, Inc. introduced a single tube real-time RT-PCR assay, Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, which simultaneously detects and differentiates Flu A,
Seegene’s Allplex™ 2019-nCoV Assay receives FDA Emergency Use Authorization
Published on: 매일경제 한국경제 PR Newswire 조선일보 SEOUL, Korea, Apr 22, 2020 – Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA)